SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001583648-18-000020
Filing Date
2018-04-25
Accepted
2018-04-25 09:01:13
Documents
5
Period of Report
2018-04-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 28043
2 EXHIBIT 99.1 a180424pirspressreleasea.htm EX-99.1 8299
3 a180424pirspressreleasea001.jpg GRAPHIC 223665
4 a180424pirspressreleasea002.jpg GRAPHIC 225556
5 a180424pirspressreleasea003.jpg GRAPHIC 39528
  Complete submission text file 0001583648-18-000020.txt   698240
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 18772857
SIC: 8731 Services-Commercial Physical & Biological Research